Mostra i principali dati dell'item

dc.creatorGoutzourelas N., Orfanou M., Charizanis I., Leon G., Spandidos D.A., Kouretas D.en
dc.date.accessioned2023-01-31T07:44:22Z
dc.date.available2023-01-31T07:44:22Z
dc.date.issued2018
dc.identifier10.3892/etm.2018.6204
dc.identifier.issn17920981
dc.identifier.urihttp://hdl.handle.net/11615/72689
dc.description.abstractThis study examined the effects of redox status markers on metabolic syndrome (MetS) and obesity before and after dietary intervention and exercise for weight loss. A total of 103 adults suffering from MetS and obesity participated in this study and followed a personalized diet plan for 6 months. Body weight, body fat (BF) percentage (BF%), respiratory quotient (RQ) and the redox status markers, reduced glutathione (GSH), thiobarbituric acid reactive substances (TBARS) and protein carbonyls (CARB), were measured twice in each individual, before and after intervention. Dietary intervention resulted in weight loss, a reduction in BF% and a decrease in RQ. The GSH levels were significantly decreased following intervention, while the levels of TBARS and CARB were not affected. Based on the initial GSH levels, the patients were divided into 2 groups as follows: The high GSH group (GSH, >3.5 µmol/g Hb) and the low GSH group (GSH <3.5 µmol/g Hb). Greater weight and BF loss were observed in patients with high GSH levels. It was observed that patients with MetS and obesity with high GSH values responded better to the dietary therapy, exhibiting more significant changes in weight and BF%. This finding underscores the importance of identifying redox status markers, particularly GSH, in obese patients with MetS. Knowing the levels of GSH may aid in developing a better design of an individualized dietary plan for individuals who wish to lose weight. © 2018, Spandidos Publications. All rights reserved.en
dc.language.isoenen
dc.sourceExperimental and Therapeutic Medicineen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85049138124&doi=10.3892%2fetm.2018.6204&partnerID=40&md5=14339dc1593f918ebcbdab9dd3f3331c
dc.subjectcarbon dioxideen
dc.subjectcarbonyl derivativeen
dc.subjectglutathioneen
dc.subjectmalonaldehydeen
dc.subjectoxygenen
dc.subjectthiobarbituric acid derivativeen
dc.subjectthiobarbituric acid reactive substanceen
dc.subjectadulten
dc.subjectantioxidant assayen
dc.subjectArticleen
dc.subjectblood analysisen
dc.subjectbody faten
dc.subjectbody massen
dc.subjectbody weight lossen
dc.subjectcardiovascular risken
dc.subjectdiabetes mellitusen
dc.subjectdiet therapyen
dc.subjecteating habiten
dc.subjectenzyme activityen
dc.subjectexerciseen
dc.subjectfemaleen
dc.subjectgenetic backgrounden
dc.subjectglycemic loaden
dc.subjecthumanen
dc.subjectinsulin resistanceen
dc.subjectkinesiotherapyen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectmetabolic syndrome Xen
dc.subjectobesityen
dc.subjectoxidative stressen
dc.subjectpersonalized medicineen
dc.subjectrespiratory quotienten
dc.subjectspectrophotometryen
dc.subjectSpandidos Publicationsen
dc.titleGsh levels affect weight loss in individuals with metabolic syndrome and obesity following dietary therapyen
dc.typejournalArticleen


Files in questo item

FilesDimensioneFormatoMostra

Nessun files in questo item.

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item